AW
NEO icon

Ankerstar Wealth’s NeoGenomics NEO Stock Holding History

Ankerstar Wealth’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233 Sell
16
-20
-56% -$193 ﹤0.01% 864
2026
Q1 		$267 Buy
36
+18
+100% +$189 ﹤0.01% 792
2025
Q4 		$212 Buy
+18
New +$194 ﹤0.01% 878

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Ankerstar Wealth's NEO Position: Q2 2026 in Review

Ankerstar Wealth reduced its NeoGenomics (NEO) stake by 56% in Q2 2026, selling an estimated $193 and leaving 16 shares worth $233. The position accounts for ﹤0.01% of the portfolio, ranked #864.

Ankerstar Wealth first reported a position in NEO in Q4 2025 and has held it in 3 quarters since. The position peaked at $267 in Q1 2026. 265 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Ankerstar Wealth held 16 shares of NeoGenomics worth $233 as of Q2 2026.
  • Ankerstar Wealth sold 20 NeoGenomics shares in Q2 2026, an estimated $193.
  • NeoGenomics made up ﹤0.01% of Ankerstar Wealth's portfolio in Q2 2026, its #864 holding.
  • Ankerstar Wealth first reported a position in NeoGenomics in Q4 2025 and has held it in 3 quarters since.
  • Ankerstar Wealth's NeoGenomics position peaked at $267 in Q1 2026.
  • 265 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Ankerstar Wealth's 13F filing for Q2 2026, filed 13 Aug 2026.